Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our study confirms the previously reported GNAQ and GNA11 mutation frequencies in UMs as well as the presence of monosomy 3 as a factor strongly indicating poor prognosis.
|
25756553 |
2015 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Activating mutations in exon 4 (R183) and exon 5 (Q209) of GNAQ and GNA 11 are almost exclusively found in uveal melanoma, thus providing a highly specific marker for the presence of circulating tumor DNA (ctDNA).
|
23634288 |
2013 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
GNAQ and GNA11 mutations in uveal melanoma.
|
25304237 |
2014 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Somatic mutations in GNAQ/11 were observed in 35/42 (83.3%) of primary UM.
|
31173078 |
2019 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
However, somatic mutations in either GNAQ or GNA11 are unique to UM tumors and could be used as potential markers to differentiate UM from metastatic CM and act as direct therapeutic targets.
|
24697775 |
2014 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Similarities with uveal melanoma were recently suggested as both entities harbor oncogenic mutations in GNAQ and GNA11.
|
25315378 |
2015 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The lack of GNAQ mutations in conjunctival melanocytic lesions suggests the involvement of a different tumorigenic pathway from that of uveal melanoma.
|
20631239 |
2010 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11.
|
23778528 |
2013 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Uveal melanoma (UM), the most common ocular malignancy, is characterized by GNAQ/11 mutations.
|
31801083 |
2019 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Recurrent coding mutations were found in the known UM drivers GNAQ, GNA11, BAP1, EIF1AX, and SF3B1.
|
27745836 |
2016 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Whereas Q209L accounts for approximately half of GNAQ mutations in UM, Q209P is as frequent as Q209L and also promotes oncogenesis, but has not been characterized at the molecular level.
|
30352874 |
2018 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
GNAQ/11 mutations in uveal melanoma: is YAP the key to targeted therapy?
|
24937456 |
2014 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The Glu209 GNAQ and GNA11 missense variants we identified are common in uveal melanoma and have been shown to constitutively activate MAPK and/or YAP signaling.
|
27058448 |
2016 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In this study, we examined the frequency of GNAQ and GNA11 somatic mutations in cases of uveal melanoma in Japan and their relationship with clinicopathologic features or Ki-67-positive cell rates (Ki-67 labeling index: Ki-67 LI) using immunofluorescence methods.
|
28248732 |
2018 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Overall, this model offers a new tool to dissect signaling by oncogenic GNAQ and to test potential therapeutics in an in vivo setting where GNAQ(Q209L) mutations contribute to both the initiation and metastatic progression of uveal melanoma.
|
26113083 |
2015 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The recent identification of frequent activating mutations in GNAQ or GNA11 in uveal melanoma provides an opportunity to better understand the pathogenesis of this melanoma subtype and to develop rational therapeutics to target the cellular effects mediated by these mutations.
|
22236444 |
2012 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our finding of the frameshift deletion (p.H387fs) in exon 4 of SOX10 in UM provides an important insight and complements earlier findings of mutations in GNAQ and SF3B1 on the genomic basis of UM.
|
24927141 |
2014 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sequencing of melanoma driver genes revealed GNAQ (p.Q209L) mutations in two samples; although it is possible that these samples represent extraocular spread of an occult uveal melanoma.
|
30558566 |
2018 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The frequencies of GNAQ and GNA11 mutations in UM were 45% (38/85) and 35% (30/85) respectively.
|
31614358 |
2019 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Further studies of uveal melanoma are required to investigate the functional and prognostic relevance of oncogenic mutations in GNA11 and GNAQ.
|
23887304 |
2014 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Activating mutations at codon 209 were identified in GNAQ in 33 (49%) of 67 primary UMs, including 2 (22%) of 9 iris melanomas and 31 (54%) of 58 posterior UMs.
|
18719078 |
2008 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma.
|
28486107 |
2017 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Oncogenic mutations in UM involving exons 4 and 5 of GNAQ and GNA11, respectively, were analysed by sequencing.
|
23456173 |
2013 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in GNAQ/11 genes are considered an early event in the development of uveal melanoma that may derive from a pre-existing nevus.
|
28809862 |
2017 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
However, GNAQ/11 mutation was genetically homogeneous between primary and metastatic melanoma lesions in uveal melanoma.
|
29361821 |
2018 |